Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enovix Corporation (ENVX) SEC filings page on Stock Titan provides access to the company’s official U.S. regulatory documents, along with AI-powered summaries to help interpret complex disclosures. As a Nasdaq-listed battery technology company focused on advanced lithium-ion cells and 100% active silicon-anode architectures, Enovix uses its SEC reports to describe financial performance, capital structure, risk factors and material events.
Through this page, you can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss Enovix’s business model, battery technology, manufacturing footprint in regions such as Malaysia and South Korea, and markets including smartphones, smart eyewear, IoT, industrial and defense applications. Our AI tools highlight key sections, such as revenue trends, operating expenses, liquidity, and the Risk Factors and MD&A discussions referenced in the company’s press releases.
You can also follow current reports on Form 8-K, where Enovix has disclosed items such as quarterly financial results, a warrant dividend distribution, authorization of a share repurchase plan, and the issuance of 4.75% Convertible Senior Notes due 2030 with related capped call transactions. These filings explain terms of the notes, conversion conditions, redemption provisions and the intended use of proceeds, including potential acquisitions in the battery ecosystem.
In addition, this page surfaces registration statements, prospectus supplements and related exhibits that describe the warrant program (ENVXW), share issuance mechanics and legal opinions, as well as any future Form 4 insider transaction reports when available. AI-generated overviews help clarify technical language, summarize covenant and event-of-default provisions, and point out changes in capital structure or share count. Together, these tools allow investors to navigate Enovix’s regulatory history more efficiently while still relying on the underlying SEC documents as the authoritative source.
Enovix Corp Chief Operating Officer Ajay Marathe reported an automatic share withholding tied to equity compensation. On January 14, 2026, 8,087 shares of Enovix common stock were withheld at $8.21 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units.
After this transaction, Marathe beneficially owns 919,334 Enovix shares. This figure includes 613,299 shares issuable upon future vesting and settlement of RSUs granted to him and 33,170 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, and the remaining half on March 1, 2027, with each PRSU representing a contingent right to receive one share of Enovix common stock.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported an automatic share withholding tied to equity compensation. On 01/13/2026, 1,080 shares of Enovix common stock were withheld at $8.02 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, she beneficially owned 192,943 shares, including 142,115 shares issuable upon future RSU vesting and settlement and 4,978 vested performance RSUs (PRSUs). Half of these PRSUs are scheduled to be released on March 2, 2026 and the remaining half on March 1, 2027, with each PRSU representing the right to receive one share upon settlement.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding on a Form 4. On January 10, 2026, 282 shares of Enovix common stock were withheld at $7.92 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owned 194,023 shares, which includes 144,031 shares issuable upon future vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). According to the disclosure, 50% of these PRSUs are scheduled to be released on March 2, 2026, with the remaining 50% scheduled for release on March 1, 2027, with each PRSU convertible into one share upon settlement.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported routine share withholding transactions related to vesting stock awards. On January 8, 2026, a total of 4,361 shares of Enovix common stock were withheld at $7.91 per share to cover tax obligations from the vesting of restricted stock units. After these transactions, Chakravarthy beneficially owned 410,459 shares of common stock directly.
The filing notes that this total includes 289,249 shares issuable upon future vesting and settlement of RSUs and 20,786 vested performance RSUs, with half of those PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. A separate ownership line reflects 282,906 RSU-based shares plus the same 20,786 vested PRSUs, underscoring that a significant portion of the position is tied to ongoing equity awards rather than currently settled shares.
Enovix Corp Chief Accounting Officer Kristina Truong reported a routine tax-related share withholding. On January 8, 2026, 1,746 shares of common stock were withheld at $7.91 per share to cover taxes due on vested restricted stock units (RSUs).
After this transaction, Truong beneficially owns 194,305 shares of Enovix common stock. This figure includes 144,507 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs), with half of the PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported routine share withholding tied to equity compensation. On January 8, 2026, 1,493 and 4,544 shares of common stock were withheld at $7.91 per share to cover tax obligations arising from vesting restricted stock units (RSUs).
After these transactions, Marathe directly holds 927,421 shares of Enovix common stock. This figure includes 635,639 shares issuable upon future RSU vesting and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. These movements reflect administrative tax withholding rather than discretionary open‑market trades.
Enovix Corporation reported that President and CEO Rajendra K. Talluri had shares of common stock withheld to cover taxes on vesting restricted stock units. On January 8, 2026, 4,301 and 13,725 shares of Enovix common stock were withheld at a price of $7.91 per share, with both transactions coded "F" and described as satisfying tax withholding obligations in connection with RSU vesting.
After these transactions, Talluri beneficially owned 2,243,254 shares of Enovix common stock directly, which includes 1,569,522 shares issuable upon settlement of RSUs and 95,551 vested performance RSUsMarch 2, 2026 and March 1, 2027, reflecting ongoing equity-based compensation rather than an open-market sale.
Enovix Corp’s Chief Operating Officer Ajay Marathe reported a tax-related share withholding tied to restricted stock units. On January 6, 2026, 42,557 shares of Enovix common stock were withheld at a price of $8.68 per share to satisfy tax obligations arising from the vesting of RSUs. After this withholding, Marathe beneficially owned 933,458 shares, including 638,458 shares issuable upon future RSU vesting and settlement and 33,170 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027, each representing the right to receive one share of Enovix common stock upon settlement.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding. On January 5, 2026, 697 shares of Enovix common stock were withheld at $8.73 per share to satisfy tax obligations tied to the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owns 196,051 shares of Enovix common stock. This amount includes 147,679 shares issuable upon future RSU vesting and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU converts into one share upon settlement.
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported an automatic share withholding tied to equity compensation. On December 24, 2025, 2,217 shares of Enovix common stock were withheld at $8.27 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Chakravarthy beneficially owned 418,228 shares, including 297,316 shares issuable upon future RSU vesting and 20,786 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half scheduled for release on March 1, 2027, each representing the right to receive one share of Enovix common stock.
FAQ
What is the current stock price of Enovix Corporation (ENVX)?
What is the market cap of Enovix Corporation (ENVX)?
